How Others are Using QbD

Organizations are gaining experience and benefits by using CTTI’s QbD recommendations to design and conduct better clinical trials.

Learn about the different strategies to help integrate QbD thinking into your team’s protocol development process, or read the case studies from others who have already implemented QbD into their trials:

Note: There is no one “right” way to implement QbD and readers are encouraged to explore the ideas presented in this case study with that understanding. In general, however, the likelihood of a successful, quality trial can be dramatically improved through proactive, cross-functional discussions and decision making about: (1) what aspects of a trial are critical to generating reliable data and providing appropriate protection of research participants (“critical to quality” factors, or CTQ factors); and, (2) what strategies and actions will effectively and efficiently support quality in these critical areas. We have structured these case studies as an in-depth look at both.

Clinical Trials Issues Related to COVID-19

Topics Included: Access to Clinical Trials, Ensuring Quality, Innovative Trials, Regulatory Submissions + Approvals

Overview

The COVID-19 pandemic caused unprecedented disruptions to nearly every aspect of clinical research.

To help, CTTI led several efforts -- including conducting surveys, holding webinars, and developing resources -- with the goal of helping the clinical trials ecosystem adapt and move forward during the pandemic, including:

Resources

How Others are Using QbD

SHARE TO: Organizations are gaining experience and benefits by using CTTI's QbD recommendations to design and conduct better clinical trials. Learn about the different strategies to help integrate QbD thinking into your...

Clinical Trials Landscape | Resources

AACT Database

AACT Database

Regulatory Submissions + Approvals | Resources

Best Practices for Designing High-Quality, Diverse COVID-19 Trials

Collating insights from across the clinical trials ecosystem, the Clinical Trials Transformation Initiative (CTTI) identified eight best practices for designing and conducting COVID-19 treatment clinical trials.

Regulatory Submissions + Approvals | Resources

Best Practices for Conducting Trials during the COVID-19 Pandemic

This document details the findings from CTTI’s surveys on ongoing trials during COVID-19 and expands on points highlighted during those corresponding webinars.

Ensuring Quality | Resources

Informing the Renovations to the ICH E6 GCP Guideline for Good Clinical Practice Executive Summary

Informing the Renovations to the ICH E6 GCP Guideline for GCP Executive Summary

Ensuring Quality | Resources

Pregnancy Testing Outcomes Predictor for Clinical Trials

Pregnancy Testing Outcomes Predictor for Clinical Trials

Regulatory Submissions + Approvals

Clinical Trials Issues Related to COVID-19

The COVID-19 pandemic turned our world upside down. And, within the clinical trials community, nearly every aspect of research experienced unprecedented disruptions.

Ensuring Quality | Resources

Critical to Quality (CTQ) Factors Principles Document

Critical to Quality (CTQ) Factors Principles Document

Ensuring Quality | CTTI News

New Case Studies Reveal Real-World Experience with Quality by Design (QbD)

Organizations are gaining experience using CTTI’s Quality by Design (QbD) recommendations to design and conduct better clinical trials. CTTI today announced four new QbD case studies, adding to its robust QbD toolkit. Three...

Ensuring Quality | Publications

Stakeholders’ recommendations for revising Good Clinical Practice

Stakeholders’ recommendations for revising Good Clinical Practice

Formats

Stage of Trial

New Case Studies Reveal Real-World Experience with Quality by Design (QbD)

Organizations are gaining experience using CTTI’s Quality by Design (QbD) recommendations to design and conduct better clinical trials. CTTI today announced four new QbD case studies, adding to its robust QbD toolkit. Three of the case studies are also now featured in CTTI’s recently-announced Building Better Clinical Trials: A Case Study Exchange resource.

The case studies provide an in-depth look at real-word implementation of QbD principles by:

  • Alexion, a biopharmaceutical company focused on developing medicines for rare diseases, applied QbD principles early in study design to build a streamlined, simple protocol for a global Phase III trial on a tight timeline.
  • An investigator at the Duke Clinical Research Institute applied QbD principles to thoughtfully and strategically design a 1,000 patient, multicenter trial that can be largely executed remotely.
  • The Medicines Company (now part of Novartis), a small pharma company that applied QbD principles with two collaborators to plan a 5-year trial that is already seeing faster-than-expected recruitment.
  • University of Oxford’s Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) followed a QbD approach in planning and conducting a streamlined, mail-based trial that enrolled over 15,000 participants.

QbD is not a checklist, rather it is a common sense approach in which stakeholders consider: (1) what aspects of a trial are critical to generating reliable data and providing appropriate protection of research participants (“critical to quality” factors); and, (2) what strategies and actions will effectively and efficiently support quality in these critical areas.

These new case studies not only describe the critical-to-quality factors for each trial, and how they were addressed, but also provide tangible strategies and examples for how other organizations can implement such an approach.

This news comes on the heels of CTTI announcing:

  • New resources for the adoption of a QbD approach – including a QbD Maturity Model, Metrics Framework, Implementation Guide, and Documentation Tool – at the end of 2020; and
  • Building Better Clinical Trials: A Case Study Exchange, announced in March 2021; three of the case studies announced today will be included in this resource.

Want to be featured on Building Better Clinical Trials: A Case Study Exchange?

If you are part of an organization that has used any of CTTI’s recommendations or tools and would like to be featured on the site, we may be able to include your story.

By sharing your experience, you can showcase your organization’s success while providing helpful information that will benefit other organizations and facilitate collaboration and knowledge sharing across the research community.

Please reach out to Karisa Merrill to learn more.